Kahn SR (2016) The post-thrombotic syndrome. Hematol Am Soc Hematol Educ Program 2016:413–418. https://doi.org/10.1182/asheducation-2016.1.413
Galanaud JP, Monreal M, Kahn SR (2018) Epidemiology of the post-thrombotic syndrome. Thromb Res 164:100–109. https://doi.org/10.1016/j.thromres.2017.07.026
Kahn SR, Shbaklo H, Lamping DL, Holcroft CA, Shrier I, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, Ginsberg JS (2008) Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 6:1105–1112. https://doi.org/10.1111/j.1538-7836.2008.03002.x
Guanella R, Ducruet T, Johri M, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Ginsberg JS, Lamping DL, Shrier I, Kahn SR (2011) Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost 9:2397–2405. https://doi.org/10.1111/j.1538-7836.2011.04516.x
Wik HS, Enden TR, Ghanima W, Engeseth M, Kahn SR, Sandset PM (2018) Diagnostic scales for the post-thrombotic syndrome. Thromb Res 164:110–115. https://doi.org/10.1016/j.thromres.2017.10.022
Wik HS, Ghanima W, Sandset PM, Kahn SR (2017) Scoring systems for postthrombotic syndrome. Semin Thromb Hemost 43:500–504. https://doi.org/10.1055/s-0037-1599142
Kahn SR, Galanaud JP, Vedantham S, Ginsberg JS (2016) Guidance for the prevention and treatment of the post-thrombotic syndrome. J Thromb Thrombolysis 41(1):144–153. https://doi.org/10.1007/s11239-015-1312-5
Article PubMed PubMed Central Google Scholar
Ten Cate-Hoek AJ (2018) Prevention and treatment of the post-thrombotic syndrome. Res Pract Thromb Haemost 2(2):209–219. https://doi.org/10.1002/rth2.12085
Article PubMed PubMed Central Google Scholar
Nielsen JD, Hermann TS, Fredskilde PCA (2024) Graduated elastic compression stockings in the prevention of post-thrombotic syndrome: a systematic review and meta-analysis. Phlebology 39:229–237. https://doi.org/10.1177/02683555231225268
Meng J, Liu W, Wu Y, Xiao Y, Tang H, Gao S (2023) Is it necessary to wear compression stockings and how long should they be worn for preventing post thrombotic syndrome? A meta-analysis of randomized controlled trials. Thromb Res 225:79–86. https://doi.org/10.1016/j.thromres.2023.03.016
Azirar S, Appelen D, Prins MH, Neumann MH, de Feiter AN, Kolbach DN (2019) Compression therapy for treating post-thrombotic syndrome. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004177.pub2
Article PubMed PubMed Central Google Scholar
Watson L, Broderick C, Armon MP (2016) Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD002783.pub4
Article PubMed PubMed Central Google Scholar
Vedantham S (2017) Thrombectomy and thrombolysis for the prevention and treatment of postthrombotic syndrome. Hematology Am Soc Hematol Educ Program 2017:681–685. https://doi.org/10.1182/asheducation-2017.1.681
Article PubMed PubMed Central Google Scholar
Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt-Montoya S, Black SA, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) (2021) Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg. 61:9–82. https://doi.org/10.1016/j.ejvs.2020.09.023.
Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ et al (2008) Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 149:698–707. https://doi.org/10.7326/0003-4819-149-10-200811180-00004
Prandoni P, Ageno W, Ciammaichella M, Mumoli N, Zanatta N, Imberti D, Visonà A, Bucherini E, Di Nisio M, Noventa F, DOAC-PTS Investigators (2020) The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants. Intern Emerg Med 15:447–452. https://doi.org/10.1007/s11739-019-02215-z
Spiezia L, Campello E, Simion C, Poretto A, Dalla Valle F, Simioni P (2022) Risk factors for post-thrombotic syndrome in patients with a first proximal deep venous thrombosis treated with direct oral anticoagulants. Angiology 73:649–654. https://doi.org/10.1177/00033197211070889
Li R, Yuan M, Cheng J, Yu S, Wei W, Fu W, Prandoni P, Chen Y (2020) Risk of post-thrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: a systematic review and meta-analysis. Thromb Res 196:340–348. https://doi.org/10.1016/j.thromres.2020.09.014
Shao J, Zhou Q, Jin F, Reissfelder C, Sigl M, Yagublu V, Keese M (2023) A systematic review and Bayesian network meta-analysis on the effect of different anticoagulants on the prophylaxis of post-thrombotic syndrome after deep venous thrombosis. J Clin Med 12:7450. https://doi.org/10.3390/jcm12237450
Article PubMed PubMed Central Google Scholar
Borgel D, Bianchini E, Lasne D, Pascreau T, Saller F (2019) Inflammation in deep vein thrombosis: a therapeutic target? Hematology 24:742–750. https://doi.org/10.1080/16078454.2019.1687144
Roumen-Klappe EM, Janssen MC, Van Rossum J, Holewijn S, Van Bokhoven MM, Kaasjager K, Wollersheim H, Den Heijer M (2009) Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study. J Thromb Haemost 7:582–587. https://doi.org/10.1111/j.1538-7836.2009.03286.x
Bouman AC, Smits JJ, Ten Cate H, Ten Cate-Hoek AJ (2012) Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome. J Thromb Haemost 10:1532–1538. https://doi.org/10.1111/j.1538-7836.2012.04798.x
Prandoni P, Ageno W, Mumoli N, Zanatta N, Imberti D, Visonà A et al (2017) Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants. Thromb Res 153:97–100. https://doi.org/10.1016/j.thromres.2017.03.022
de Athayde SR, Matielo MF, Brochado Neto FC, Almeida RD, Sacilotto R (2020) Ultrasound Aspects and Recanalization Rates in Patients with Lower-Limb Deep Venous Thrombosis Treated with Rivaroxaban. Ann Vasc Surg 67:293–299. https://doi.org/10.1016/j.avsg.2020.01.017
Spiezia L, Campello E, Giolo E, Villalta S, Prandoni P (2010) Thrombophilia and the risk of post-thrombotic syndrome: retrospective cohort observation. J Thromb Haemost 8:211–213. https://doi.org/10.1111/j.1538-7836.2009.03655.x
Rabinovich A, Cohen JM, Prandoni P, Kahn SR (2014) Association between thrombophilia and the post-thrombotic syndrome: a systematic review and meta-analysis. J Thromb Haemost 12:14–23. https://doi.org/10.1111/jth
Spiezia L, Campello E, Dalla Valle F, Simion C, Colpo A, Simioni P (2018) ABO blood group and the risk of post-thrombotic syndrome. Ann Hematol 97:1057–1060. https://doi.org/10.1007/s00277-018-3255-3
Campello E, Spiezia L, Simion C, Tormene D, Camporese G, Dalla Valle F et al (2020) Direct oral anticoagulants in patients with inherited thrombophilia and venous thromboembolism: a prospective cohort study. J Am Heart Assoc 9:e018917. https://doi.org/10.1161/JAHA.120.018917
Article PubMed PubMed Central Google Scholar
Campello E, Spiezia L, Adamo A, Simioni P (2019) Thrombophilia, risk factors and prevention. Expert Rev Hematol 12:147–158. https://doi.org/10.1080/17474086.2019.1583555
Karathanos C, Nana P, Spanos K, Kouvelos G, Brotis A, Matsagas M, Giannoukas A (2021) Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: a systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord 9:1568-1576.e1. https://doi.org/10.1016/j.jvsv.2021.04.016
Brown C, Tokessy L, Delluc A, Carrier M (2024) Risk of developing post thrombotic syndrome after deep vein thrombosis with different anticoagulant regimens: a systematic review and pooled analysis. Thromb Res 240:109057. https://doi.org/10.1016/j.thromres.2024.109057
Comments (0)